Re: Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy with Brachytherapy Boost and Disease Progression and Mortality in Patients with Gleason Score 9-10 Prostate Cancer

Affiliations

¹ Duke Cancer Institute, Durham, NC, USA; Department of Urology, Shiraz University of Medical Sciences, Shiraz, Iran.
² Duke Cancer Institute, Durham, NC, USA. Electronic address: thomas.polascik@dm.duke.edu.

Comment

Alireza Aminsharifi et al. Eur Urol. 2018 Oct.

. 2018 Oct;74(4):526.

doi: 10.1016/j.eururo.2018.05.031. Epub 2018 Jun 8.

¹ Duke Cancer Institute, Durham, NC, USA; Department of Urology, Shiraz University of Medical Sciences, Shiraz, Iran.
² Duke Cancer Institute, Durham, NC, USA. Electronic address: thomas.polascik@dm.duke.edu.

No abstract available

Comment on

Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Stephenson AJ, Klein EA, Song DY, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco S, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR. Kishan AU, et al. JAMA. 2018 Mar 6;319(9):896-905. doi: 10.1001/jama.2018.0587. JAMA. 2018. PMID: 29509865 Free PMC article.